Anavex Life Sciences
AVXL
#7952
Rank
โ‚ฌ0.28 B
Marketcap
3,08ย โ‚ฌ
Share price
3.14%
Change (1 day)
-62.10%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -โ‚ฌ42.2 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ44.02 Million a decrease over its 2023 earnings that were of -โ‚ฌ38.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ42.2 Million-4.14%
2024 -โ‚ฌ44.02 Million14.77%
2023 -โ‚ฌ38.35 Million-17.49%
2022 -โ‚ฌ46.48 Million22.96%
2021 -โ‚ฌ37.8 Million35.36%
2020 -โ‚ฌ27.93 Million12.65%
2019 -โ‚ฌ24.79 Million29.09%
2018 -โ‚ฌ19.21 Million36.33%
2017 -โ‚ฌ14.09 Million17.11%
2016 -โ‚ฌ12.03 Million20.91%
2015 -โ‚ฌ9.95 Million-6.29%
2014 -โ‚ฌ10.62 Million337.28%
2013 -โ‚ฌ2.43 Million
2008 -โ‚ฌ4.49 Million106.01%
2007 -โ‚ฌ2.18 Million8848.98%
2006 -โ‚ฌ0.03 Million-79.99%
2005 -โ‚ฌ0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ0.13 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ38.24 M-195.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ4.1 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.22 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA